Montelukast and worsening of hallucinations in paranoid schizophrenia

Psychiatric Bulletin

Volumn 32, Issue 7, 2008, Pages 276-

  Anandan, Nithya ^a   Ibitoye, Fade ^a  

^a WHISTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; MONTELUKAST; QUETIAPINE;

ADULT; ANAMNESIS; ASTHMA; AUDITORY HALLUCINATION; CASE REPORT; DRUG CONTRAINDICATION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HALLUCINATION; HUMAN; LETTER; PARANOID SCHIZOPHRENIA; SOMATIC DELUSION; SYMPTOMATOLOGY; TACHYCARDIA; VISUAL HALLUCINATION;

EID: 46749148823     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.32.7.276     Document Type: Letter

References (2)

1. NETHERLANDS PHARMACOVIGILANCE CENTRE (2007) Montelukast and Depressive Symptoms. Netherlands Pharmacovigilance Centre (http://www.lareb.nl/documents/kwb_2006_4_montel.pdf).
2. PRICE, D. (2000) Tolerability of montelukast. Drugs, 59 (suppl 1), 35-42.